Abstract
Background: The diagnosis of asthma is confirmed with a spirometry: FEV1 ratio (forced expiratory volume in one second)/FVC (forced vital capacity) <80% with reversibility (FEV1 >12% or 200 mL) after using salbutamol. The peak expiratory flow is cheap and easy to use; it measures the forced expiratory flow, of which reversibility > 20% suggests asthma.
Objective: To know the sensitivity, specificity, and the positive and negative predictive values of the flowmeter.
Methods: A cross-sectional, observational, comparative study. Individuals aged >18 years without contraindications for spirometry were included. They underwent spirometry and peak expiratory flow, and the ACT (Asthma Control Test) questionnaire was applied to them. Sensitivity, specificity, positive predictive value and negative predictive value of the flowmetry were calculated. ROC curve was carried out in order to know the cut-off point of greater sensitivity and specificity.
Results: Of 150 patients, 66% were male; the median age was 38 years. According to the guidelines of GINA 2018 (Global Initiative for Asthma); 58.7% were controlled. The sensitivity of the peak expiratory flow was 47%, and the specificity was 87%, with a positive predictive value of 54.8% and a negative predictive value of 84%. The peak expiratory flow showed higher specificity with FEV1 <59%. The cut-off point of greater sensitivity and specificity was a reversibility of 8%, with an area under the curve of 0.70.
Conclusions: The flowmeter has got greater sensitivity in airway obstructions; it is useful when a spirometer is not available.
References
Global Strategy for Asthma Management and Prevention. EE. UU: Global Initiative for Asthma; 2018.
Plaza-Moral V, Comité Ejecutivo de GEMA. GEMA (4.3). Guidelines for Asthma Management. Arch Bronconeumol. 2018;51(Suppl 1):2-54. DOI: 10.1016/S0300-2896(15)32812-X
Asher MI, Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee. Clin Exp Allergy. 1998;28(Suppl 5):52-66-91. DOI: 10.1046/j.1365-2222.1998.028s5052.x
Larenas-Linnemann D, Salas-Hernández J, Vázquez-García JC, Ortiz-Aldana I, Fernández-Vega M, Del Río-Navarro BE, et al. Guía Mexicana del Asma 2017. Rev Alerg Mex. 2017;64(Supl 1):s11-s128. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2017/nts171a.pdf
Solé D, Sánchez-Aranda C, Falbo-Wandalsen G. Asthma: epidemiology of disease control in Latin America – short review. Asthma Res Pract. 2017;3:4. DOI: 10.1186/s40733-017-0032-3
Vargas-Becerra MH. Epidemiología del asma. Neumol Cir Torax. 2009;68(Supl 2):S91-S97.
Vargas MH, Díaz-Mejía GS, Furuya ME, Salas J, Lugo A. Trends of asthma in Mexico: an 11-year analysis in a nationwide institution. Chest. 1993;125(6):1993-1997.
Kawayama T, Kinoshita T, Matsunaga K, Naito Y, Sasaki J, Tominaga Y, et al. Role of regulatory T cells in airway inflammation in asthma. Kurume Med J. 2018;64(3):45-55. DOI: 10.2739/kurumemedj.MS6430001
Quirt J, Hildebrand K, Mazza J, Noya F, Harold K. Asthma. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):50. Disponible en: https://aacijournal.biomedcentral.com/articles/10.1186/s13223-018-0279-0
Staitieh BS, Ioachimescu OC. Interpretation of pulmonary function tests: beyond the basics. J Investig Med. 2017;65(2):301-310. DOI: 10.1136/jim-2016-000242
Pérez-Padilla R, Bouscoulet-Torre L, Vázquez-García JC, Muiño A, Márquez M, Victorina-López M, et al. Valores de referencia para la espirometría después de la inhalación de 400 μg de salbutamol. Arch Bronconeumol. 2007;43(10):530-534. Disponible en: https://s3.amazonaws.com/alatoldsite/images/stories/demo/pdf/departamentos/fisiopato/valorespostbd.pdf
García-Río F, Calle M, Burgos F, Casan P, et al. Normativa sobre espirometría 2013. España: Sociedad Española de Neumología y Cirugía Torácica; 2013. Disponible en: http://www.hca.es/huca/web/enfermeria/html/f_archivos/Normativa%20Separ%20Espirometria.pdf
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. DOI: 10.1183/09031936.05.00034805
Benítez-Pérez RE, Torre-Bouscoulet L, Villca-Alá N, Del Río-Hidalgo RF, Pérez-Padilla R, Vázquez-García JC, et al. Espirometría: recomendaciones y procedimiento. 2006;75(2):173-190. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2016/nt162g.pdf
Lefebvre Q, Vandergoten T, Derom E, Marchandise E, Liistro G. Testing spirometers: are the standard curves of the American thoracic society sufficient. Respir Care. 2014;59(12):1895-1904. DOI: 10.4187/respcare.02918
Antunes BO, De Souza HC, Gianinis HH, Passarelli-Amaro RC, Tambascio J, Gastaldi AC. Peak expiratory flow in healthy, young, non-active subjects in seated, supine, and prone postures. Physiother Theory Pract. 2016;32(6):489-493. DOI: 10.3109/09593985.2016.1139646
Dombkowski KJ, Hassan F, Wasilevich EA, Clark SJ. Spirometry use among pediatric primary care physicians. Pediatrics. 2010;126(4):682-687. DOI: 10.1542/peds.2010-0362
Ram FS, McNaughton W. Giving Asthma Support to Patients (GASP): a novel online asthma education, monitoring, assessment and management tool. J Prim Health Care. 2014;6(3):238-244. DOI: 10.1071/HC14238
Nakaie CM, Rozov T, Manissadjian. A comparative study of clinical score and lung function tests in the classification of asthma by severity of disease. Rev Hosp Clin Fac Med Sao Paulo. 1998;53(2):68-74.
Pérez-Padilla R, Vollmer WM, Vázquez-García JC, Enright PL, Menezes AM, Buist AS, et al. Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis. 2009;13(3):387-393. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334276/
Troyanov S, Ghezzo H, Cartier A, Malo JL. Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects. Thorax. 1994;49(8):775-780. DOI: 10.1136/thx.49.8.775
Pesola GR, O’Donnell P, Pesola GR, Chinchilli VM, Saari AF. Peak expiratory flow in normals: comparison of the mini Wright versus spirometric predicted peak flows. J Asthma. 2009;46(8):845-848.
Kitaguchi Y, Yasuo M, Hanaoka M. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation. Int J Chron Obstruct Pulmon Dis. 2016;11:991-997. DOI: 10.1164/ajrccm-conference.2011.183.1
Eid N, Yandell B, Howell L, Eddy M, Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics. 2000;105(2):354-358. DOI: 10.1542/peds.105.2.354
Gautrin D, D’Aquino LC, Gagnon G, Malo JL, Cartier A. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic. Chest. 1994;106(5):1419-1426. DOI: 10.1378/chest.106.5.1419
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2019 Revista Alergia México